packageErlotinib

erlotinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Erlotinib is a tyrosine-kinase inhibitor used to treat cancers, mainly non-small-cell lung cancer and pancreatic cancer. It is approved and authorised in the European Union, and is used in cancer treatment.

Summary written by glm-5.3-flash from Wikidata Q418369 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:erlotinib
ATC codes:L01EB02, L01XE03
DrugBank:DB00530
PubChem CID:176870
ChEBI:114785
Wikidata:Q418369
formula:C22H23N3O4
molar mass:393.443 g/mol (PubChem CID 176870)
logP:3.3 (Drugs.Common 25.09, not verified)

Metabolites

OSI420OSI-420379.416 g/mol (pubchem)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown

Contents

NameDescription
OSI420metabolite: OSI-420